Randomised, open label study of rituximab/ibrutinib vs rituximab/chemotherapy in older patients with untreated mantle cell lymphoma
Phase of Trial: Phase II/III
Latest Information Update: 26 Jan 2017
At a glance
- Drugs Ibrutinib (Primary) ; Bendamustine; Cyclophosphamide; Doxorubicin; Prednisolone; Rituximab; Rituximab; Vincristine
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- Acronyms ENRICH
- 26 Jan 2017 New source identified and integrated. (EudraCT2015-000832-13; European Clinical Trials Database).
- 24 Nov 2015 Status changed from not yet recruiting to recruiting as reported by ISRCTN: Current Controlled Trials record.
- 14 Oct 2015 New trial record